Download presentation
Presentation is loading. Please wait.
Published byShawn Wheeler Modified over 9 years ago
1
Expect more with Siegfried as your preferred partner Siegfried at a glance
2
Commitment of some 850 employees First choice in compliance, responsiveness and reliability Over 130 years of continuity, global presence Process Development experience from over 1,600 substances, extensive services Overview
3
3 Our Vision Expect more with Siegfried as your preferred partner Bringing together our long-standing pharma and chemical heritage, we offer as an integrated partner benefit to our customers with more synergy, expertise and value. Explore more about how our broad range of custom development services, drug substance & drug product manufacturing capabilities, together with our existing product portfolio may help you achieve greater value.
4
4 Overview Locations
5
5 Overview Past do Present 1873Pharmacist Samuel Benoni Siegfried founds a company with 12 employees as a supplier to pharmacies 1904 Conversion into a joint stock corporation 1937Founding of Ganes Chemical Works, Inc. (NJ, USA) 1973Quotation on the Swiss Stock Exchange (SWX) in Basel 1991Focus on development and custom manufacturing 2001Building of two core divisions: Siegfried and Sidroga
6
6 Overview Past to Present 2001Integration of Ganes into the Siegfried Group = Siegfried (USA) Inc. 2005Acquisition of Penick Corporation in New Jersey, USA 2007Launch of a new pharmaceutical production facility in Malta Sale of the Sidroga Division Sale of the biotech activities 2008 Sale of the pharmaceutical production site Zofingen 2010Definition of new strategy «Transform» Implementation of a new function- based organisation. New investors and capital increase. Sale of Munich, Germany subsidiary (Pulmojet project) to Sanofi-Aventis.
7
7 Strategy Position
8
8 Drug Substances Custom synthesis of APIs and intermediates, as well as production of standard substances, particularly controlles substances for analgesics and narcotics. Drug Products Process development and production of complex drug products and finished dosage forms. Products & Services Two Strong Business Areas Business Area Products & Services
9
Gilbert Achermann Chairman Felix Meyer Reto Garzetti Thomas Villiger. Andreas Casutt Reto Garzetti Management Board of Directors
10
Arnoud Middel Head Human Resources Peter Gehler Head Corporate Center Secretary to the Board of Directors Rudolf Hanko Chief Executive Officer Michael Hüsler Chief Financial Officer Walter Kittl Head Technical Operations Marianne Späne Head Business Development & Sales Wolfgang Wienand. Chief Scientific Officer, Head of Strategy and M & A Management Executive Committee René Imwinkelried Head Research & Development
11
11 Human Resources Vision Socially responsible employer Motivated and talented personnel Mutual respect Personal responsibility Focusing on results
12
Expect more with Siegfried as your preferred partner Thank you for your attention
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.